Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] At-the-Market Offering Program [Member] Private Placement [Member] Asset Class [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Award Date [Axis] 2013 Through March 31, 2025 [Member] Legal Entity [Axis] Israeli Innovation Authority [Member] Business Acquisition [Axis] CardioSert Ltd [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Ministry of Economy [Member] Technion Research and Development Foundation Limited [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Product and Service [Axis] Device [Member] Integrated Product [Member] Securities Purchase Agreement [Member] Litigation Settlement [Member] Title and Position [Axis] CEO, Executives [Member] Certain Employees [Member] Series G Preferred Investment Options [Member] Series H Preferred Investment Options [Member] Series I Preferred Investment Options [Member] Exercise Of Investment Options [Member] Class of Stock [Axis] Series E Preferred Investment Options [Member] Chief Executive Officer [Member] Management [Member] Chief Executive Officer and Other Executives [Member] Advisors [Member] Executives [Member] Certain Employees and Certain Board Members [Member] Board [Member] Warrant To Underwriters October 2022 [Member] Warrant To Underwriters One May 2023 [Member] Warrant To Underwriters Two May 2023 [Member] Warrant to Underwriters One June 2023 [Member] Warrant to Underwriters Two June 2023 [Member] Warrant Series E January 2024 [Member] Warrant to Underwriters January 2024 [Member] Warrant Series F June 2024 [Member] Warrant to Underwriters June 2024 [Member] Warrant Series G January 2025 [Member] Warrant To Underwriters January 2025 [Member] Warrant Series H January 2025 [Member] Warrant To Underwriters January 2025 One [Member] Warrant To Underwriters January 2025 Two [Member] Warrant Series I February 2025 [Member] Warrant to Underwriters February 2025 [Member] Segments [Axis] Other Operating Segment [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Series E and Series F Preferred Investment Options [Member] Series F Preferred Investment Options [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Marketable securities Restricted cash Prepaid expenses and other current assets Total current assets Property and equipment, net Operating right-of-use assets Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable Lease liabilities Accrued liabilities Total current liabilities Non-current liabilities: Long-term lease liabilities Total liabilities Shareholders’ equity: Common stock; $0.01 par value; 60,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 34,744,476 and 19,399,513 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively. Additional paid-in capital Accumulated deficit Total shareholders’ equity Total liabilities and shareholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Research and development, net General and administrative Operating loss Other income (see Note 3G) Financing income, net Net loss Basic net loss per share Diluted net loss per share Basic weighted average common shares outstanding Diluted weighted average common shares outstanding Statement [Table] Statement [Line Items] Balances Balance, shares Issuance of common stock and warrants net of issuance costs Issuance of common stock and warrants net of issuance costs, shares Issuance of common stock relating to settlement agreement Issuance of common stock relating to settlement agreement, shares Share-based compensation Net loss Issuance of common stock under the at-the-market offering program Issuance of common stock under the at-the-market offering program, shares Issuance of common stock upon exercise of warrants Issuance of common stock upon exercise of warrants, shares Balances Balances, shares Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Issuance costs Stock issuance cost not paid Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to net cash flows used in operating activities: Depreciation of property and equipment Share-based compensation Changes in assets and liabilities: Prepaid expenses and other assets Other payables and accrued liabilities Insurance recovery related to legal settlement and legal expenses received in cash Legal settlement paid in cash Net cash flows used in operating activities Investing activities: Purchases of property and equipment Purchases of marketable securities Proceeds from sales of a marketable securities Proceeds from maturities of marketable securities Net cash flows used in investing activities Financing activities: Issuance of common stock and warrants, net of issuance costs Net cash flows provided by financing activities Increase (decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental disclosure of non-cash investing and financing activities: Right-of-use assets obtained in exchange for lease liabilities Deferred expenses offset against additional paid in capital Issuance expenses not paid Legal settlement settled through issuance of common stock Accrued bonus settled through grant of stock-option awards Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHARE CAPITAL Segment Reporting [Abstract] SEGMENT REPORTING Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation: Use of estimates: Fair value of financial instruments: Share-based compensation: Recently adopted accounting pronouncements: Accounting pronouncements not yet effective: SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF STATEMENT OF OPERATION BY SEGMENT Date of incorporation Cash equivalents and marketable securities Impairment Effects on Earnings Per Share [Table] Impairment Effects on Earnings Per Share [Line Items] Marketable securities Loss Contingencies [Table] Loss Contingencies [Line Items] Revenue grants received Grants receivable Additional grant receivable Repayment of government grants Net sales royalty percenatge Offering costs Aggregate offering Percentage of placement fee Gross proceeds from cash fee percentage Gross proceeds from management fee percentage Warrant issued, descriptions Stock issued during period, value, new issues Royalties percentage Purchase price of plaintiffs Litigation settlement amount Payment for litigation settlement Restricted common shares issued for legal settlement Liabilities current Assets current Settlement amount recovery Legal expense Non operating loss on legal settlement Insurance recovery amount Number of share issued Proceeds from Legal Settlements Accrued bonuses Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of outstanding warrants Exercise price Exercisable Through Issued shares Share price per share Placement agent fee Offering expense Sale of Stock, Consideration Received on Transaction Total gross proceeds Other offering expenses Stock Issued During Period, Value, Stock Options Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of options granted Weighted-average exercise price per share, granted Additional number of stock options granted Compensation expenses Compensation percentage Annual bonus Number of options vested Number of options forfeited Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Payroll and payroll related Materials and subcontractors Share-based compensation Other segment items Subsequent Event [Table] Subsequent Event [Line Items] Gross proceeds from option exercise Number of options outstanding Cash fee Options issued Accounting Pronouncements Not Yet Effective [Policy Text Block] Marketable Securities [Member] 2013 through June 30, 2024 [Member] Israeli Innovation Authority [Member] Additional grant receivable. Repayment of government grants. CardioSert Ltd [Member] Net sales royalty percentage. Ministry of Economy [Member] Technion Research And Development Foundation Limited [Member] Technology [Member] Cardio Sert [Member] Offering costs. At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Placement fee percent. Gross proceeds from management fee percentage. Gross proceeds from cash fee percentage. Royalties percent. Device [Member] Integrated Product [Member] Securities Purchase Agreement [Member] Litigation Settlement [Member] Stock issued during period value warrants exercised. Stock issued during period shares warrants exercised. Stock issued during period value settlement agreement. Stock issued during period shares settlement agreement. At-the-Market Offering Program [Member] Interest income and unrealized gains from marketable securities net. Increase decrease in legal settlement and legal expenses received in cash. Increase decrease in legal settlement. Accrued bonus settled through grant of stock-option awards. Deferred expenses offset against additional paid in capital. Issuance expenses not paid. Insurance recovery amount. Alliance Investment Management, Ltd. [Member] Joseph Mona [Member] Other Executives [Member] Chief Financial Officer and Chief Technology Officer [Member] CEO, Executives [Member] Certain Employees [Member] Series G Preferred Investment Options [Member] Series H Preferred Investment Options [Member] Series I Preferred Investment Options [Member] Exercise Of Investment Options [Member] Series E Preferred Investment Options [Member] Additional share based compensation arrangement by share based payment award options grants in period gross. Chief Executive Officer and Other Executives [Member] Advisors [Member] Annual bonus Executives [Member] Certain Employees and Certain Board Members [Member] Board [Member] Series A Warrant October 2022 [Member] Class of warrant or righst month year from which warrants or rights exercisable. Warrant To Underwriters October 2022 [Member] Warrant To Underwriters One May 2023 [Member] Warrant To Underwriters Two May 2023 [Member] Warrant to Underwriters One June 2023 [Member] Warrant Series C June 2023 [Member] Warrant to Underwriters Two June 2023 [Member] Warrant Series D June 2023 [Member] Warrant Series E January 2024 [Member] Warrant to Underwriters January 2024 [Member] Warrant Series F June 2024 [Member] Warrant to Underwriters June 2024 [Member] Warrant Series G January 2025 [Member] Warrant To Underwriters January 2025 [Member] Warrant Series H January 2025 [Member] Warrant To Underwriters January 2025 One [Member] Warrant Series I January 2025 [Member] Warrant To Underwriters January 2025 Two [Member] Warrant To Underwriters January 2025 Three [Member] Payroll and payroll related Materials and subcontractors Schedule of Long Lived Assets and Operating Lease Right of Use Assets By Geographical Areas [Table Text Block] Long lived assets and operating lease right of use assets Series E and Series F Preferred Investment Options [Member] 2013 Through March 31, 2025 [Member] Warrant Liability. Schedule Of Warrant Liability [Table Text Block] Warrant Series I February 2025 [Member] Warrant to Underwriters February 2025 [Member] Stock issuance costs payable. Assets Liabilities Equity, Attributable to Parent Liabilities and Equity Research and Development Expense General and Administrative Expense Operating Income (Loss) Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInLegalSettlementAndLegalExpensesReceivedInCash Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Held-to-Maturity Securities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Assets, Fair Value Disclosure Gain (Loss) from Litigation Settlement Segment Reporting, Other Segment Item, Amount